(Total Views: 105)
Posted On: 05/13/2025 10:20:15 AM
Post# of 96
BNGO - Why “RISK” OGM
American companies that share their intellectual property (IP) with China often face significant risks, including forced technology transfers, IP theft, and regulatory manipulation. The Chinese government has a history of leveraging its legal and regulatory system to coerce technology transfer or appropriate foreign innovations for domestic use. High-profile cases, such as DuPont, Micron, and Tesla, illustrate how Chinese entities have allegedly exploited partnerships, poached talent, and engaged in outright theft to gain access to proprietary technologies. Additionally, China’s Cybersecurity Law grants its government broad access to data stored within its borders, raising concerns about espionage and unauthorized IP extraction.
BUT, Bionano Genomics, for reasons unkown, feels it is an exception to the Chinese threat.
Enter the partnership with Diagens, a Chinese company
American companies that share their intellectual property (IP) with China often face significant risks, including forced technology transfers, IP theft, and regulatory manipulation. The Chinese government has a history of leveraging its legal and regulatory system to coerce technology transfer or appropriate foreign innovations for domestic use. High-profile cases, such as DuPont, Micron, and Tesla, illustrate how Chinese entities have allegedly exploited partnerships, poached talent, and engaged in outright theft to gain access to proprietary technologies. Additionally, China’s Cybersecurity Law grants its government broad access to data stored within its borders, raising concerns about espionage and unauthorized IP extraction.
BUT, Bionano Genomics, for reasons unkown, feels it is an exception to the Chinese threat.
Enter the partnership with Diagens, a Chinese company
(0)
(0)
